240 results on '"Candido, Riccardo"'
Search Results
2. Open questions on basal insulin therapy in T2D: a Delphi consensus
3. Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform
4. Diabete e sindrome metabolica nel paziente con iperaldosteronismo primario
5. Tirzepatide in aggiunta a insulina basale nel trattamento del diabete tipo 2: risultati del trial SURPASS-6
6. Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care
7. Profiles of sulfonylurea use in Diabetes Mellitus type 2: an analysis of clinical practice over the last 10 years
8. Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study
9. Assessment of E/A ratio helps emergency clinicians in the management of patients with acute dyspnea
10. 2023 update on Italian guidelines for the treatment of type 2 diabetes
11. Effetto della semaglutide in pazienti obesi con insufficienza cardiaca a frazione di eiezione preservata
12. A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy
13. Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group
14. Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study
15. Gestational diabetes mellitus: Impact of adherence on patient management and maternal-neonatal complications
16. Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study
17. Italian guidelines for the treatment of type 2 diabetes
18. Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
19. Treatment intensification following glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE‐G real‐world study.
20. Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
21. Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies
22. Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice
23. Prevalence and risk factors of glomerular hyperfiltration in adults with type 2 diabetes: A population‐based study.
24. Overcoming Therapeutic Inertia in Type 2 Diabetes: Exploring Machine Learning-Based Scenario Simulation for Improving Short-Term Glycemic Control.
25. Strategies used by Patients with Type 1 Diabetes to Avoid Hypoglycemia in a 24×1-Hour Marathon: Comparison with the Amounts of Carbohydrates Estimated by a Customizable Algorithm
26. Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study.
27. A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
28. Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study
29. Angiotensin 1–7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro
30. Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes.
31. ACE2 deficiency shifts energy metabolism towards glucose utilization
32. Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction?
33. Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group.
34. Preliminary Study on the Effect of a Night Shift on Blood Pressure and Clock Gene Expression.
35. The incidence rate and prevalence of pediatric type 1 diabetes mellitus (age 0–18) in the Italian region Friuli Venezia Giulia: population-based estimates through the analysis of health administrative databases
36. Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB
37. Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: A retrospective cohort study.
38. Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events.
39. Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative
40. Does metabolic syndrome worsen systolic dysfunction in diabetes? The shortwave study
41. Analysis of Left Atrial Performance in Patients with Type 2 Diabetes Mellitus without Overt Cardiac Disease and Inducible Ischemia: High Prevalence of Increased Systolic Force Related to Enhanced Left Ventricular Systolic Longitudinal Function
42. TRAIL shows potential cardioprotective activity
43. Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells.
44. Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
45. All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials.
46. La territorializzazione del farmaco in epoca di PNRR: prospettive, opportunità e spunti di riflessione da un panel di esperti.
47. Effects of prolonged high-altitude exposure on peripheral adrenergic receptors in young healthy volunteers
48. Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure
49. Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo
50. Hypertension and Diabetes: Emphasis on the Renin-Angiotensin System in Atherosclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.